Antisense Therapeutics
Posted: Mon Oct 03, 2005 12:48 pm
Antisense Therapeutics were trialling an oral drug which targeted the same protein as Tysabri. The company stopped the trial following the Tysabri fiasco. The company has applied to restart the trial (may need to add to Dignan's list of approval given).
http://www.antisense.com.au/dl/415.pdf
http://www.antisense.com.au/dl/415.pdf